CHICAGO, IL USA (UroToday.com) - Presented by Grace L. Lu-Yao, MPH, PhD,1 Peter C. Albertsen, MD,2 Dirk F. Moore, PhD,1 Weichung Shih, PhD,1 Yong Lin, ,PhD,1 Robert S. DiPaola, MD1,1 and Siu-Long Yao, MD1, 3 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Click HERE to listen to an interview with Siu-Long Yao, MD, one of the authors of the study
Click HERE to read the abstract
1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
2Department of Surgery (Urology), University of Connecticut, Farmington, CT USA
3Merck Research Laboratories, Kenilworth, NJ USA